Coinfection: Clinical Trials

76 trials for Coinfection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 11 unknown, 7 recruiting, 6 terminated. 12 Phase 4, 10 Not applicable, 8 Phase 2, 8 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 412Completed 4, Unknown 4, Withdrawn 3, Terminated 1
Not applicable10Completed 6, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 28Completed 7, Unknown 1
Phase 38Completed 5, Recruiting 1, Terminated 1, Withdrawn 1
Phase 13Completed 3
Early Phase 11Completed 1

Follow Coinfection: new trials by email Literature Review of Coinfection trials Research Report on Coinfection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics
sampling blood, Lavage with physiologic saline solution - ARDS (Acute Respiratory Distress Syndrome)
RecruitingMedical University of Vienna1302026-07-012026-07-10
Community-acquired Pneumonia Due to Chlamydia Pneumoniae
Community-Acquired Pneumonia
Not yet recruitingCentre Hospitalier de Saint-Denis2002026-06-012026-07-01
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia
RecruitingAzienda Ospedaliero-Universitaria Careggi4002025-11-132026-07-02
Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression
Interferon Gamma 1-b, Placebo - Sustained Immunosuppression
Phase 3RecruitingUniversity Hospital, Limoges3262025-07-092025-11-20
Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
HBV, HCV
RecruitingVanessa Stadlbauer-Koellner, MD1002025-05-012026-06-18
Host Immunity, Plasmodium and Pathogens Co-Infections
Blood sample, Urine sample, oropharyngeal sample - Malaria, Bacterial Co-infection
Not applicableNot yet recruitingInstitut Pasteur20002025-02-152025-01-24
Role of Transposable Elements in Septic Immune Aging
RNA and DNA Sequencing - Sepsis, Sepsis and Septic Shock
RecruitingUniversity of California, San Francisco1162025-02-142026-01-30
Analysis of Single Respiratory Viral Infections Versus Co-infections: Prevalence and ICU Needs in Hospitalized Adults
Respiratory Tract Infections, Virus Diseases
CompletedKocaeli University2312025-01-122025-07-08
Emergency PWAS in Respiratory Infectious Disease
Biomarker blood draw and saliva collection - Viral Infections, Bacterial Infections
RecruitingThe University of Hong Kong20002023-04-112026-05-12
Model to Predict Coinfection in Elderly Patients With COVID-19
Covid19
CompletedXiangya Hospital of Central South University10002022-12-202024-03-21
Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos
COVID Prevention Program (CPP) - SARS-CoV-2 Infection
Not applicableActive not recruitingSan Diego State University2562022-04-112025-01-28
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19
Previously admitted COVID-19 patients in intensive care units - COVID-19
CompletedThe University of Queensland7902022-02-142023-05-22
Virus Interactions in the Respiratory Tract; a Cohort Study With Children
No intervention - Respiratory Tract Infections, Coinfection
CompletedUMC Utrecht2292021-09-152024-05-09
Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
Oral Paste(0,5 g) containing 10 mg of polymyxin B, 10 mg of gentamycin and 150 mg of amphotericine B or 500 000 U of nistatin q6h, Suspension (10 ml) containing 100 mg of polymyxin B, 80 mg of gentamycin, 350 mg of amphotericine B or 8000000 U of nistation and 500 mg of vancomycin q6h, Intravenous Antibacterial Agent - a 3-day course of systemic cefotaxime 1 g q6h or ceftriaxone 1 g qd - Pneumonia, Ventilator-Associated, Pneumonia
Not applicableUnknownMEDSI Clinical Hospital 1, ICU602021-05-012021-06-08
Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French Guiana
An additional 5 mL venous blood tube taken from patients during their routine medical check-up at the hospital - Hepatitis B, Chronic, Adults
UnknownCentre Hospitalier de Cayenne4002021-02-112021-05-13
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy
Hepatitis C Virus Infection, Hepatitis C Virus Infection, Response to Therapy of
UnknownNational Taiwan University Hospital3002021-02-092021-02-26
Inflammation and Co-Infections in D²EFT
NRTIs, Darunavir, Ritonavir - HIV-infection/Aids, Human Herpesvirus 4 Infections
Phase 4WithdrawnKirby Institute2021-02-012020-11-10
Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19
vibroacoustic therapy - SARS CoV 2 Infection
CompletedAstana Medical University12020-09-292022-01-12
LILLE COVID RESEARCH NETWORK (Covid-19)
Sars-CoV2
CompletedUniversity Hospital, Lille7572020-08-102025-12-23
Pediatric Immune Response to Multi-Organ Dysfunction
Blood test - Multiple Organ Dysfunction Syndrome
Not applicableCompletedHospices Civils de Lyon1862020-07-292024-05-29

Showing 20 of 76. Sign in to see all of them.

Narrower conditions

HIV Infections (24)  ·  Hepatitis C (21)  ·  Acquired Immunodeficiency Syndrome (15)  ·  COVID-19 (8)  ·  Hepatitis B (8)  ·  Tuberculosis (7)  ·  Hepatitis C, Chronic (6)  ·  Malaria (6)  ·  Pneumonia (6)  ·  Respiratory Tract Infections (5)  ·  Mycoses (4)  ·  Sepsis (4)  ·  Bacterial Infections (3)  ·  Diarrhea (3)

Broader conditions

Infections (73)  ·  RNA Virus Infections (51)  ·  Virus Diseases (51)  ·  Blood-Borne Infections (43)  ·  Communicable Diseases (43)  ·  Immune System Diseases (36)  ·  Genital Diseases (35)  ·  Immunologic Deficiency Syndromes (35)  ·  Lentivirus Infections (35)  ·  Retroviridae Infections (35)  ·  Sexually Transmitted Diseases (35)  ·  Sexually Transmitted Diseases, Viral (35)  ·  Urogenital Diseases (35)  ·  Digestive System Diseases (26)  ·  Hepatitis, Viral, Human (26)

Interventions

Ribavirin (7)  ·  peginterferon alfa-2a (5)  ·  Albendazole (4)  ·  Praziquantel (3)  ·  Raltegravir Potassium (3)  ·  Ritonavir (3)  ·  efavirenz (3)  ·  peginterferon alfa-2b (3)  ·  Blood Specimen Collection (2)  ·  Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2)  ·  Lopinavir (2)  ·  N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (2)  ·  Nevirapine (2)  ·  Observation (2)  ·  atazanavir, ritonavir drug combination (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (8)  ·  University of Washington (4)  ·  University of Florida (3)  ·  AbbVie (2)  ·  Bayside Health (2)  ·  African Poverty Related Infection Oriented Research Initiative (1)  ·  Anna Cruceta (1)  ·  Asan Medical Center (1)  ·  Astana Medical University (1)  ·  Azienda Ospedaliero-Universitaria Careggi (1)  ·  Centre Hospitalier de Cayenne (1)  ·  Centre Hospitalier de Saint-Denis (1)  ·  Chinese University of Hong Kong (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Derm Research, PLLC (1)

Countries

United States (14)  ·  China (6)  ·  Spain (6)  ·  France (5)  ·  Canada (4)  ·  Ghana (4)  ·  Kenya (4)  ·  Russia (4)  ·  Australia (3)  ·  Austria (3)  ·  South Korea (3)  ·  Argentina (2)  ·  Brazil (2)  ·  India (2)  ·  Ireland (2)

Top investigators

Awewura Kwara, MD (3)  ·  Judd L Walson, MD, MPH (3)  ·  Alexander Wong, MD (1)  ·  Alexander Y Debrah, PhD (1)  ·  Alexendar R Perez, M.D., Ph.D (1)  ·  Amy D Klion, M.D. (1)  ·  Andrea Graham, PhD (1)  ·  Anthony E Samir, MD (1)  ·  Baraka Amuri, MD (1)  ·  Bich-Tram Huynh, PhD (1)  ·  Bonaventura Clotet, MD, PhD (1)  ·  Charles H. Hinkin, PhD (1)  ·  Charlotte Hobbs, MD (1)  ·  Chen-Hua Liu, MD (1)

Results publications

PMID 32682494, PMID 10189326, PMID 10218526, PMID 10371175, PMID 10546860, PMID 10563713, PMID 10634199, PMID 10789605, PMID 10971863, PMID 10988097, PMID 11071184, PMID 11188837, PMID 11216928, PMID 11262215, PMID 11366976, PMID 11399982, PMID 11719381, PMID 11722270, PMID 11737323, PMID 11740189, PMID 11807691, PMID 12008784, PMID 12126821, PMID 12134254, PMID 12172088, PMID 12186514, PMID 12534953, PMID 12553482, PMID 12558340, PMID 12640206, PMID 12741625, PMID 12819520, PMID 12853195, PMID 12859325, PMID 12891060, PMID 12957089, PMID 14518432, PMID 14581998, PMID 14627784, PMID 14991809, PMID 14999610, PMID 15195254, PMID 15197808, PMID 15232720, PMID 15234856, PMID 15272393, PMID 15273954, PMID 15285167, PMID 15316340, PMID 15316342

NIH funding

R01HD071779 (3), 2004 (2), 2005 (1), R01AI049141 (1), R01AI065256 (1), R01HD079695 (1), R01MH083553 (1), R34MH099930 (1), U01AI068632 (1)